Baker Brothers Advisors - PASSAGE BIO INC ownership

PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 91 filers reported holding PASSAGE BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of PASSAGE BIO INC
ValueSharesWeighting
Q2 2022$276,000
-24.0%
117,1610.0%0.00%0.0%
Q1 2022$363,000
-51.2%
117,1610.0%0.00%
-50.0%
Q4 2021$744,000
-36.2%
117,1610.0%0.00%
-20.0%
Q3 2021$1,167,000
-24.8%
117,1610.0%0.01%
-28.6%
Q2 2021$1,551,000
-62.3%
117,161
-50.2%
0.01%
-61.1%
Q1 2021$4,114,000
-31.6%
235,3620.0%0.02%
-21.7%
Q4 2020$6,018,000
+75.8%
235,362
-9.8%
0.02%
+64.3%
Q3 2020$3,423,000
-54.5%
261,066
-5.1%
0.01%
-57.6%
Q2 2020$7,516,000
+73.5%
275,0000.0%0.03%
+22.2%
Q1 2020$4,331,000275,0000.03%
Other shareholders
PASSAGE BIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,497,922$1,648,6292.12%
Versant Venture Management, LLC 4,959,769$3,263,5281.74%
BML Capital Management, LLC 2,058,767$1,354,6691.24%
Acuitas Investments, LLC 418,161$275,1500.16%
Orbimed Advisors 10,124,576$6,661,9710.14%
Lynx1 Capital Management LP 190,124$125,1020.08%
Frazier Life Sciences Management, L.P. 1,758,219$1,156,9080.08%
TANG CAPITAL MANAGEMENT LLC 400,000$263,2000.04%
Marquette Asset Management, LLC 86,050$56,6210.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 506,600$333,3430.01%
View complete list of PASSAGE BIO INC shareholders